This information note provides a factual account of the UK’s financial and strategic engagement with the Global Fund, to coincide with the Global Fund’s seventh round of replenishment in September 2022.
- The Global Fund’s organisational effectiveness, impact and value for money are highly rated by external bodies.
- The COVID-19 pandemic has had a severe impact on the Global Fund’s efforts to tackle AIDS, tuberculosis and malaria, as well as its impact on broader health systems.
- Most areas of testing and treatment for the three diseases have seen a decline, including significant drops in the numbers treated for malaria and tuberculosis.
- This is the first time that key programmatic results have declined globally during the 20-year history of the Global Fund.
- As part of its commitment to the Global Fund for the sixth replenishment in 2019, the UK established a performance agreement with the Global Fund. This was linked to a £100 million performance tranche, which was dependent on the Global Fund achieving certain conditions. These have been met to date.
- The Global Fund’s replenishment model has been very successful and has led to a significant increase in resources over the course of the Fund’s 20-year lifespan.
- The UK government has yet to pledge for the seventh replenishment and is later in doing so than it was for the sixth replenishment.
- It has also delayed some of its payments under the sixth replenishment, but a commitment has been made to Parliament that the government is on track to fulfil its 2019 pledge.
Read the news story